The Significance of Postoperative Muscle Wasting in Pancreatic Cancer

NCT06093009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2023-10-24

No results posted yet for this study

Summary

To assess the impact of preoperative sarcopenia and postoperative skeletal muscle wasting on the outcomes of patients with resectable pancreatic cancer who underwent pancreatectomy.

Conditions

Interventions

PROCEDURE

pancreatectomy

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2020-04-30
Completion
2023-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06093009 on ClinicalTrials.gov